Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now includes a comprehensive list of trial locations, including U.S. states, Canadian provinces, and select international sites. This addition helps potential participants identify nearby enrollment centers and plan participation.SummaryDifference1%

- Check17 days agoChange DetectedAdded a new 'Last Update Posted (Estimated)' timestamp and removed the plain 'Last Update Posted' field in the Study Record Dates section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded Banner North Colorado Medical Center - Loveland Campus to the list of study locations and removed Banner McKee Medical Center. Updated the page's last update timestamp to reflect these changes.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded a PubMed auto-fill note and updated the revision to v3.3.1, while removing the previous PubMed-based description (v3.2.0).SummaryDifference0.0%

- Check45 days agoChange DetectedRemoved the site-wide notice about government funding lapse and NIH operations status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.